The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.
about
Male microchimerism in the human female brainThe cholinergic hypothesis of Alzheimer's disease: a review of progressAlmitrine-Raubasine combination for dementiaAlmitrine-Raubasine combination for dementiaDonepezil for vascular cognitive impairmentIn vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Alzheimer disease: progress or profit?Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patientsPathogenesis of Alzheimer's diseaseAlzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairmentHuman cerebral neuropathology of Type 2 diabetes mellitusRepair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Movement disorders in Alzheimer's disease: more rigidity of definitions is needed.High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's diseaseAccuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.Pick body disease and Pick syndrome.Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.Chronic traumatic encephalopathy in a national football league player: part II.National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's diseaseParkinson's disease mimicking senile dementia of the Alzheimer type: a clinicopathological study of four autopsy cases.Effect of vascular lesions on cognition in Alzheimer's disease: a community-based studyAggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's diseaseMagnetoencephalography as a putative biomarker for Alzheimer's diseaseCerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathySingle-channel quantitative multiplex reverse transcriptase-polymerase chain reaction for large numbers of gene products differentiates nondemented from neuropathological Alzheimer's disease.Counting dementia: There is no one "best" wayAnosmia is very common in the Lewy body variant of Alzheimer's disease.Preclinical AD Workgroup staging: pathological correlates and potential challenges.Neurovascular and neurometabolic derailment in aging and Alzheimer's disease.Practical Principles for the Management of Alzheimer's Disease.Evolution of the diagnostic criteria for degenerative and cognitive disorders.Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognitionOverview and findings from the religious orders studyClinical trials in mild cognitive impairment: lessons for the future.Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease.Factors affecting the age of onset and rate of progression of Alzheimer's disease.Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.
P2860
Q21134035-A243CA51-17B1-490A-BCA5-68186DE0C5D8Q22242019-49AE9C43-B612-4EFA-90B7-FF2A8DD30F51Q24235696-924D3254-029A-4469-AE19-D79041F986D9Q24241067-C7E9D098-A4DB-4EDF-A46E-E6F524936A50Q24250149-69F50D1B-AD76-4179-8ED3-7E1B050772DFQ24630918-B3AB8306-9719-4F7E-AEDD-408ADEDA303DQ28251041-87AA0742-56F6-434C-9846-459339CD7C6FQ28264001-FC66D564-B076-4C49-B8CC-27A1435680ADQ30439489-D0FC9875-83A0-4E7A-9B26-CD299F57C095Q33406823-23CE62AF-5417-485B-BBAE-CBA97F7A5684Q33710643-42053450-DF58-44AB-A0F1-3B0EF367AD66Q33769079-CE8FC618-DF5C-4B75-9C1D-2A035424908DQ33816861-EC0E31EC-CCF5-4F2F-B32E-E31007434D9EQ34209319-928FFD31-AD40-47AC-B501-2255E53944B5Q34262758-2D8A34D4-63BD-4D9B-B36B-7F60660227DFQ34289458-FC264FE7-6858-45D6-ACD6-EFD789518301Q34577636-7E88B08D-213D-46F2-88E0-543F34DE5B2EQ34586844-4B57F5BE-6034-4A4F-8740-A9E05471F897Q34635272-2DA9CBD0-0123-4DCB-8F26-EB788324DAA1Q34698588-BE94B352-4B08-4C1B-AC82-507E34A1F63BQ34709029-32F464C9-1FC1-4ABA-8DE7-DB2B4EE9C63EQ34873879-269FE09D-4A71-405F-8060-314D52B4F850Q34923627-DFE5A2DC-5199-41DE-957D-2135C5534AF7Q35005803-5B83E656-EF0B-4DA9-A1FA-34643F96039AQ35009495-F11491A2-D871-441E-91D0-074B97DC2834Q35081397-AE5BDBE5-93E9-4974-8236-91154CFAC8F5Q35094655-F2C3659A-7134-4F82-91D8-5DA2FFD79FF5Q35096832-4968764F-3CDF-48B2-885D-68A4031C75D7Q35484548-F816127D-D86D-4BF8-A432-FE30BB5304DBQ35633470-3723D1B2-56C8-42D0-9F7A-3C973325C9AFQ35651255-FC578F07-A0DD-4DB5-A0F9-2CB0C4CA291EQ35667052-F176E762-FFF4-4887-8C53-481C8481899DQ35708394-38E3FD38-137D-48FC-8AB5-82DA972788C7Q35754523-4101EA5A-47F6-4B92-B533-E1226295DA8BQ35963453-AC4DCB27-FDDF-4DD9-9FFF-25BF4420024DQ36130996-EF683039-6310-4812-9C89-8EB06DFBEA10Q36142255-578690E4-7589-421E-B54C-552CCBC61B73Q36317646-9672E9F3-F182-4039-AEAA-FED7EBCE4D55Q36318577-62423B8E-D044-44FA-8B91-608E1D927853Q36404504-03BA6C23-AD44-4C1C-B000-D74A0F4F8618
P2860
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@ast
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@en
type
label
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@ast
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@en
prefLabel
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@ast
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@en
P2093
P356
P1433
P1476
The Consortium to Establish a ...... gnosis of Alzheimer's disease.
@en
P2093
P304
P356
10.1212/WNL.45.3.461
P407
P433
P577
1995-03-01T00:00:00Z